{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-308342","form_type":"8-K","ticker":"RGNX","cik":"0001590877","company_name":"REGENXBIO Inc.","filed_at":"2026-07-20T11:34:30+00:00","discovered_at":"2026-07-20T11:35:00.296711+00:00","generated_at":"2026-07-20T11:35:05.461956+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"REGENXBIO prices $100M public offering of common stock and pre-funded warrants","bullets":["Offering of 10,003,889 shares at $9.00/share and 1,111,111 pre-funded warrants at $8.9999 each.","Gross proceeds ~$100M; net proceeds ~$107.8M after underwriters' full exercise of 1,667,250 option shares.","Underwriters: Morgan Stanley, J.P. Morgan, Leerink Partners, Mizuho Securities.","Expected to close July 20, 2026, subject to customary conditions.","Pre-funded warrants have $0.0001 exercise price, exercisable immediately, no expiration."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-308342","json":"https://secwatch.observer/filing/0001193125-26-308342.json","markdown":"https://secwatch.observer/filing/0001193125-26-308342.md","text":"https://secwatch.observer/filing/0001193125-26-308342.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590877/000119312526308342/0001193125-26-308342-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590877/000119312526308342/d40931d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-20T11:35:05.461956+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}